COMPARISON OF CA19-9 WITH OTHER TUMOR-MARKERS IN THE DIAGNOSIS OF CANCER OF THE PANCREAS
COMPARISON OF CA19-9 WITH OTHER TUMOR-MARKERS IN THE DIAGNOSIS OF CANCER OF THE PANCREAS
复制标题
DOI：
10.1097/00006676-199411000-00008
复制
发表时间：
1994-11-01
期刊：
影响因子：
2.9
通讯作者：
TAKEUCHI, T
中科院分区：
文献类型：
--
作者：
SATAKE, K;TAKEUCHI, T
The carbohydrate antigen 19-9 (CA19-9) and radioimmunoassay have been shown to offer new hope for improving the diagnosis of pancreatic cancer, and various tumor markers (including SPan-1, DUPAN-2, and CA50) have been established. While clinical studies of these markers have found satisfactory sensitivities, only a few studies have compared these tumor markers on the same blood samples. We therefore evaluated the clinical efficacy of SPan-1, CA19-9, DUPAN-2, CA50, carcinoembryonic antigen, and Elastase 1 in detecting pancreatic cancer in identical blood samples.
